# Longitudinal Study of the Human Intestinal Microbiome

> **NCT00832286** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (actual)

## Conditions studied

- Dysbacteriosis

## Interventions

- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT00832286
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-23
- **Primary completion:** 2010-09-24
- **Final completion:** 2011-01-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832286, "Longitudinal Study of the Human Intestinal Microbiome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00832286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*